Press Releases

Category: Partnerships


Collaboration with Microsoft to support business scale up with global pharma

IXICO plc, the AI data analytics company delivering insights in neuroscience, announces a collaboration with Microsoft to develop its AI data analytics platform for the global pharmaceutical industry.

Read more

IXICO and NYU Langone Health sign agreement to develop novel imaging markers in multiple system atrophy

IXICO plc announces that it has entered into an agreement with NYU Langone Health to support a trial to determine if the immunosuppressant drug Sirolimus – approved by the FDA to prevent organ transplant rejection and for the treatment of a rare and progressive lung disease called lymphangioleiomiomatosis - is also able to slow the...

Read more

IXICO joins the TRACK-FA Neuroimaging Consortium to develop novel imaging markers in Friedreich's Ataxia

IXICO plc announces that it has entered into a 5 year collaboration with the Friedreich's Ataxia Research Alliance (FARA), a non-profit organization dedicated to the pursuit of scientific research leading to treatments and a cure for Friedreich's Ataxia (FA).

Read more

Global Alzheimer's Platform Foundation selects IXICO for innovative Bio-Hermes trial

IXICO plc, the data analytics company delivering insights in neuroscience, announces that it has been selected by the Global Alzheimer's Platform Foundation® (GAP) to support GAP's planned Bio-Hermes trial.

Read more

IXICO announces an expanded contract for its imaging services with Vaccinex

Supports Vaccinex's diversification into clinical development of pepinemab for Alzheimer's disease We are delighted to announce an award of a contract to provide imaging services for Vaccinex Inc. 's planned Phase Ib/IIa trial of pepinemab, a potential treatment of Alzheimer's disease (AD).

Read more

IXICO supports the Alzheimer's Disease Neuroimaging Initiative

IXICO today announced funding support for the Alzheimer's Disease Neuroimaging Initiative (ADNI), and two of their scientists will join the ADNI-Private Partner Scientific Board (PPSB). Watch our Chief Product Officer, Alison Howie's interview with proactive to learn more about IXICO's role within the ADNI partnership.

Read more

IXICO participating at the CPAD 2019 Annual Meeting & Regulatory Science Workshop

Dr Robin Wolz, SVP of Science & Innovation at IXICO, will be attending the CPAD 2019 Annual Meeting & Regulatory Science Workshop on Oct 29 in Arlington, Virginia (USA).

Read more

IXICO's Katherine Gray to present at the AMYPAD General Assembly Meeting

Dr Katherine Gray, Associate Director in Clinical Science at IXICO, will be presenting at the AMYPAD General Assembly Meeting (10-11 Oct) in Barcelona, Spain.   IXICO is currently collecting data for both the AMYPAD DPMS (eCRF and imaging data) and PNHS (imaging data) studies using our proprietary data management platform, TrialTrackerTM.

Read more

1-8 of 9 results